NextSource Biotechnology Announces FDA Short Supply Release of the Formally Known Bristol Myers Squibb (CeeNuÂ®) Brand Oncology Product Now Currently Marketed Under the NextSource Biotechnology Lomustine (CCNU) Exclusively i